 BETHESDA, Md., Jan. 12, 2023 GLOBE NEWSWIRE -- Gain Therapeutics, Inc. Nasdaq: GANX Gain, or the Company, a biotechnology company transforming drug discovery with its proprietary computational discovery platform identifying novel allosteric binding sites and creating small molecule treatments, today announced that Matthias Alder, CEO, will present a corporate update at the Sidoti Small-Cap Virtual Investor Conference on Wednesday, January 18 at 2:30 PM ET. 